Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer

Clinical trial NCT03344211 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03344211
Sponsor: University of Southern California
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Prostate Carcinoma Metastatic in the Bone Stage IV Prostate Cancer

Start date: 2018-11-21
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.